USA061 — Maywood, Illinois

USA061 is a clinical research site located in Maywood, Illinois, United States 60153.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

USA061 has participated in 1 clinical trials.

Therapeutic areas: Non-Cystic Fibrosis Bronchiectasis.

Sponsors: Insmed Incorporated.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Maywood

Browse all research sites in Illinois · View every site in Maywood

• Loyola University Medical Center - Neurology
• Loyola University Medical Center at Loyola in Chicago
• Loyola University Medical School
• Loyola University Chicago at Loyola University Medical Center
• Loyola University Chicago - Cardinal Bernadin Cancer Center
• Loyola University Medical Center Foster McGraw Hospital
• Loyola University Chicago Medical Center
• Loyola University Chicago Health Sciences Division
• Loyola University Cardinal Bernardin Cancer Center
• Loyola University Med. Ctr.
• Loyola University Medical Center /Cardinal Bernardin Cancer Cardinal Bernardin Cancer (3)
• Stritch School of Medicine Loyola University

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for USA061?

USA061 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has USA061 conducted?

USA061 has 1 clinical trials on record. Their work covers Non-Cystic Fibrosis Bronchiectasis.

Is USA061 accredited by Crixeo Clinical Trials?

USA061 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about USA061?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.